Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07075627 · ClinicalTrials.gov registry record
A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
A clinical trial, sponsored by Addario Lung Cancer Medical Institute.
- Not yet
- Registry status
- 400
- Enrollment target
NCT07075627 is a clinical trial that has not yet begun recruiting, run by Addario Lung Cancer Medical Institute. The registered enrollment target is 400 participants.
The verdict
NCT07075627 has not yet begun recruiting, sponsored by Addario Lung Cancer Medical Institute.
- NOT YET RECRUITING
- Registry status
- 400 participants
- Enrollment target
Study Summary
This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-09 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07075627
The ClinicalTrials.gov registry entry for NCT07075627 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Addario Lung Cancer Medical Institute, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07075627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07075627 about?
NCT07075627 is a clinical study titled "A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)". This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.
What is the current status of trial NCT07075627?
This trial is currently not yet recruiting. The enrollment target is 400 participants. The study started on 2025-09. Estimated completion is 2026-12.
Who is sponsoring clinical trial NCT07075627?
This trial is sponsored by Addario Lung Cancer Medical Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.